Federated Hermes, Inc. Silk Road Medical Inc Transaction History

Federated Hermes, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$16.95 - $27.04 $163,787 - $261,287	9,663 Added 965.33%	10,664 $288,000
Q1 2024 May 14, 2024	SELL	$11.38 - $19.03 $5.36 Million - $8.96 Million	-470,776 Reduced 99.79%	1,001 $18,000
Q4 2023 Jan 31, 2024	BUY	$6.29 - $15.72 $2.97 Million - $7.42 Million	471,777 New	471,777 $5.79 Million
Q4 2022 Feb 13, 2023	BUY	$40.54 - $56.2 $40 - $56	1 New	1 $0
Q1 2021 May 13, 2021	SELL	$46.31 - $62.7 $6.55 Million - $8.87 Million	-141,432 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$55.51 - $69.94 $3.85 Million - $4.85 Million	-69,313 Reduced 32.89%	141,432 $8.91 Million
Q3 2020 Nov 12, 2020	BUY	$42.19 - $69.61 $8.89 Million - $14.7 Million	210,745 New	210,745 $14.2 Million
Q1 2020 May 13, 2020	SELL	$23.16 - $47.8 $2.8 Million - $5.78 Million	-120,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$27.97 - $40.38 $584,573 - $843,942	20,900 Added 20.9%	120,900 $4.88 Million
Q2 2019 Aug 14, 2019	BUY	$32.5 - $49.12 $3.25 Million - $4.91 Million	100,000 New	100,000 $4.85 Million

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.